• FirefoxInstall the new Firefox »
  •  Dow Up 0.21% Nasdaq Up 0.32%

    Novo Nordisk A/S (NVO)

    -NYSE
    46.84 Down 0.21(0.45%) Mar 5, 4:03PM EST
    Add to Portfolio
    Prev Close:47.05
    Open:46.92
    Bid:47.06 x 4900
    Ask:47.24 x 4900
    1y Target Est:58.52
    Beta:0.75
    Next Earnings Date:N/A
    Day's Range:46.65 - 47.09
    52wk Range:41.72 - 49.11
    Volume:945,203
    Avg Vol (3m):1,348,250
    Market Cap:121.77B
    P/E (ttm):31.02
    EPS (ttm):1.51
    Div & Yield:0.76 (1.60%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NVODown 0.45%121.77B
    LLYDown 0.08%74.87B
    PFEDown 0.49%211.26B
    SNYUp 0.04%127.26B

    Key Statistics

    Forward P/E (1 yr):24.91
    P/S (ttm):9.18
    Ex-Dividend Date:19-Mar-15

    Analysts

    Annual EPS Est (Dec-14) :N/A
    Quarterly EPS Est (Jun-14) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback